158 related articles for article (PubMed ID: 15926117)
1. Relationship between antidiabetic treatment with QT dispersion during acute coronary syndromes in type 2 diabetes: comparison between patients receiving sulfonylureas and insulin.
Tentolouris N; Matsagura M; Psallas M; Chatzizacharias A; Fotia M; Arvanitis M; Katsilambros N
Exp Clin Endocrinol Diabetes; 2005 May; 113(5):298-301. PubMed ID: 15926117
[TBL] [Abstract][Full Text] [Related]
2. QT-interval dispersion in type 2 diabetic and non-diabetic patients with post-myocardial infarction.
Sakabe K; Fukuda N; Fukuda Y; Wakayama K; Nada T; Morishita S; Shinohara H; Tamura Y
Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):121-6. PubMed ID: 17346952
[TBL] [Abstract][Full Text] [Related]
3. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of QT dispersion for acute coronary syndrome in patients presenting with chest pain and nondiagnostic initial electrocardiograms.
Pekdemir M; Karaca I; Cevik Y; Yanturali S; Ilkay E
Mt Sinai J Med; 2006 Sep; 73(5):813-7. PubMed ID: 17008945
[TBL] [Abstract][Full Text] [Related]
5. [Increase of the QT interval dispersion in diabetes mellitus].
Lengyel C; Várkonyi T; Boda K; Fazekas T
Orv Hetil; 1997 Feb; 138(6):337-41. PubMed ID: 9082291
[TBL] [Abstract][Full Text] [Related]
6. [Value and circadian variations of QT dispersion in patients with diabetes mellitus and coronary artery disease].
Bissinger A; Markuszewski L; Rosiak M
Pol Merkur Lekarski; 2008 Feb; 24(140):90-4. PubMed ID: 18634261
[TBL] [Abstract][Full Text] [Related]
7. [QT interval dispersion in hypertensive diabetics and in patients with hypertension with chronic heart failure without diabetes].
Radman A; Murín J; Bulas J; Reptová A; Ravingerová T; Mikes P; Kozliková K; Ghanem W; Jaber J; Baqi L
Vnitr Lek; 2003 Oct; 49(10):802-7. PubMed ID: 14682153
[TBL] [Abstract][Full Text] [Related]
8. The effect of sulphonylurea therapy on the outcome of coronary heart diseases in diabetic patients.
Pogatsa G; Koltai MZ; Jermendy G; Simon J; Aranyi Z; Ballagi-Pordany G
Acta Med Hung; 1992-1993; 49(1-2):39-51. PubMed ID: 1296186
[TBL] [Abstract][Full Text] [Related]
9. Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus.
Ravipati G; Aronow WS; Ahn C; Sujata K; Saulle LN; Channamsetty V; Weiss MB
Am J Ther; 2006; 13(5):400-3. PubMed ID: 16988534
[TBL] [Abstract][Full Text] [Related]
10. Coronary heart disease outcomes in patients receiving antidiabetic agents.
McAfee AT; Koro C; Landon J; Ziyadeh N; Walker AM
Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):711-25. PubMed ID: 17551989
[TBL] [Abstract][Full Text] [Related]
11. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
Habib SS; Aslam M; Naveed AK; Razi MS
Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
[TBL] [Abstract][Full Text] [Related]
12. QT dispersion in type 2 diabetic patients with altered diurnal blood pressure rhythm.
Deyneli O; Ersöz HO; Yavuz D; Fak AS; Akalin S
Diabetes Obes Metab; 2005 Mar; 7(2):136-43. PubMed ID: 15715886
[TBL] [Abstract][Full Text] [Related]
13. Effects of transient myocardial ischemia on the QT interval in man.
Kerr CR; Hacking A; Henning H
Can J Cardiol; 1987; 3(8):383-6. PubMed ID: 3427536
[TBL] [Abstract][Full Text] [Related]
14. [Predictor of early thrombolysis in acute coronary syndrome by estimation of the QT interval variability on 12 lead standard electrocardiogram].
Gegeshidze ND; Tabukashvili RI; Tsikarishvili SSh; Pagava ZT; Mamaladze GT
Georgian Med News; 2005 Nov; (128):35-7. PubMed ID: 16369060
[TBL] [Abstract][Full Text] [Related]
15. Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide).
Klamann A; Sarfert P; Launhardt V; Schulte G; Schmiegel WH; Nauck MA
Eur Heart J; 2000 Feb; 21(3):220-9. PubMed ID: 10639304
[TBL] [Abstract][Full Text] [Related]
16. The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes mediation by superoxide production, resolution with intensive insulin administration.
Worthley MI; Holmes AS; Willoughby SR; Kucia AM; Heresztyn T; Stewart S; Chirkov YY; Zeitz CJ; Horowitz JD
J Am Coll Cardiol; 2007 Jan; 49(3):304-10. PubMed ID: 17239711
[TBL] [Abstract][Full Text] [Related]
17. Type of preadmission antidiabetic treatment and outcome among patients with ischemic stroke: a nationwide follow-up study.
Horsdal HT; Mehnert F; Rungby J; Johnsen SP
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):717-25. PubMed ID: 21536457
[TBL] [Abstract][Full Text] [Related]
18. Role of previous treatment with sulfonylureas in diabetic patients with acute myocardial infarction: results from a nationwide French registry.
Danchin N; Charpentier G; Ledru F; Vaur L; Guéret P; Hanania G; Blanchard D; Lablanche JM; Genès N; Cambou JP
Diabetes Metab Res Rev; 2005; 21(2):143-9. PubMed ID: 15386810
[TBL] [Abstract][Full Text] [Related]
19. QT dispersion and myocardial viability in patients after acute myocardial infarction.
Kosmala W; Przewlocka-Kosmala M; Halawa B
Int J Cardiol; 2004 Apr; 94(2-3):249-54. PubMed ID: 15093989
[TBL] [Abstract][Full Text] [Related]
20. Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.
Aquilante CL; Zhang W; McCollum M
Curr Med Res Opin; 2007 Mar; 23(3):489-94. PubMed ID: 17355730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
